Single enzyme helps drive inflammation in mice, provides target for new sepsis drugs

Researchers have discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides a new and unexpected therapeutic target for new drug development.